Exocrine Insufficiency

11/11/2011 Management of Exocrine Insufficiency David C Whitcomb MD PhD Giant Eagle g Foundation Professor of Cancer Genetics Professor of Medicine, ...
Author: Rolf Hoover
2 downloads 0 Views 428KB Size
11/11/2011

Management of Exocrine Insufficiency David C Whitcomb MD PhD Giant Eagle g Foundation Professor of Cancer Genetics Professor of Medicine, Cell Biology & Physiology, and Human Genetics Chief, Division of Gastroenterology, Hepatology and Nutrition University of Pittsburgh and UPMC.

Outline: EPI in pancreatic disease Syndromes with EPI Need for PERT Goals for PERT Recommendations

1

11/11/2011

Clinical Course of CP Where do you start treatment? How much is enough? Should the dose be changed?

Pancreatic Function

Time (years)

Clinical Course of CP

Patient B Pancreatic Function Patient C

Patient A

Time (years)

2

11/11/2011

PEI – major question • • • • •

Which disorders commonly have PEI? What are the signs that PEI is present? Is PEI a sign of an irreversible state? What are the goals of treatment? How should the patient’s condition be monitored?

Conditions Associated with

Pancreatic Exocrine Insufficiency Mechanism M h i

Examples E l

Acinar cell dysfunction

SDS (diabetes mellitus*)

Acinar cell destruction

chronic pancreatitis, severe acute pancreatitis

Acinar cell removal

pancreatectomy

Duct dysfunction

cystic fibrosis

Duct blockage

IPMN, pancreatic cancer, parasites

Hypostimulation

(Celiac disease, Crohn’s disease)

Enzyme destruction

Zollinger-Ellison syndrome

Asynchrony

gastroparesis, gastric bypass surgery

* Subsets of all types of DM Whitcomb, 2011

3

11/11/2011

Syndromes with variable PEI • • • •

Autoimmune pancreatitis (reversible) Inflammatory bowel disease (overlap syndrome?) Celiac Disease (reversible) Diabetes Mellitus (complex)

Syndromes with Pancreatic Insufficiency: AIP • Autoimmune pancreatitis  Type 1: lymphoplasmacytic-sclerosis l h l i l i x Elevated IgG4 x IgG4-associated Systemic Disease (ISD)

 Type 2: granulocyte epithelial lesion (GEL) x IgG4 may be normal x Associated with IBD (especially UC)

 May present with vague abdominal discomfort and symptoms of malabsorption  Pancreatic exocrine insufficiency may be reversed with steroid treatment Zhang et al Pancreas 2011;40: 1172-1179

4

11/11/2011

Syndromes with Pancreatic Insufficiency: IBD • Inflammatory Bowel Disease  Pancreatic diseases is common in both Crohn’s disease and UC  Acute pancreatitis is common during treatment with immunomodulators (e.g. azothioprine) p y, p pancreatic p pathology gy is p present in 4 40%  At autopsy, of people with Crohn’s disease  Pancreatic exocrine insufficiency may be present in 10-15% of patients with IBD, especially in those with diarrhea.

Syndromes with Pancreatic Insufficiency: Celiac Disease • Celiac Disease  Complex pathophysiology of pancreatic insufficiency x Mucosal injury and decreased CCK release x Poor nutritional status – especially protein malnutrition x Coexisting chronic pancreatitis

 Diarrhea from exocrine pancreatic insufficiency improves with pancreatic enzyme replacement therapy.  Pancreatic Insufficiency is reversible!

5

11/11/2011

Fecal elastase 1 µG//g stool

Celiac Disease – PEI is reversible 500 400 300 200 100 0 0

6 m.

F/U (45-60m)

Time point • PEI in 30% (20/66) of adult celiac patients with persistent diarrhea • 95% (19 of 20) improved with PERT (BM from 4 Æ 1 per day, p

Suggest Documents